Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma is a registry-stage clinical asset sponsored by ASH Research Collaborative in Multiple Myeloma. SEO and diligence focus: Patient Reported Outcomes, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.